Papers
6
Total Citations
229
H-Index
4
About
Dr. Kian Behbakht is a leading gynecologic oncologist whose research focuses on optimizing surgical outcomes and postoperative care for women with gynecologic malignancies. His most impactful work addresses the critical challenge of preventing venous thromboembolism (VTE) after cancer surgery. In a landmark 2020 study (133 citations), Dr. Behbakht demonstrated the safety and efficacy of apixaban compared to standard enoxaparin for postoperative thromboprophylaxis, offering a more cost-effective and patient-friendly alternative that could improve adherence rates. He has also been a pioneer in evaluating robotic surgery for endometrial cancer, particularly in older patients. His comparative studies (2015, 45 and 24 citations) showed that robotic staging is safe and effective for women aged 65 and older, challenging age-based surgical biases. Further, his 2016 analysis (21 citations) identified key factors influencing the adoption of robotic surgery across the United States. Dr. Behbakht’s work on hemostatic agents (2014) also revealed an important association with postoperative abscess formation, improving surgical safety. With a career dedicated to advancing minimally invasive techniques and evidence-based thromboprophylaxis, his research directly enhances recovery and quality of life for women facing gynecologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6